Protalix BioTherapeutics (PLX) – Analyst Ratings
-
Protalix BioTherapeutics (PLX) PT Raised to $2.10 at Jefferies; Funding Risk Removed
-
Jefferies Cuts Price Target on Protalix BioTherapeutics (PLX) After Meeting with Management
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Back to PLX Stock Lookup